This completed Phase 1/2 trial tested a new DNA booster vaccine called Covigenix VAX-002 in 46 healthy adults aged 18 and older. The vaccine is designed to protect against newer COVID-19 variants like Omicron. Participants had already received a primary COVID-19 vaccine or booste…
Phase: PHASE1, PHASE2 • Sponsor: Entos Pharmaceuticals Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:04 UTC